GLP-1 Drugs Show Promise in Curbing Drug and Alcohol Cravings

A growing body of evidence suggests that GLP-1 drugs, already used for diabetes and weight loss, may also help reduce cravings for drugs and alcohol. Researchers are testing whether these medications can be a new tool in tackling the nation's addiction crisis. William Brangham reports on the science behind this potential breakthrough. In this segment from our series "GLP-1s: Reshaping America," we explore the stories of individuals who have experienced reduced cravings and the researchers studying the effects. Early findings are promising, but questions remain about long-term efficacy and access. The implications for addiction treatment could be profound. We also examine the challenges of bringing these treatments to those who need them most and the ongoing clinical trials. As the opioid epidemic continues, any new avenue for treatment is welcome news. This report offers a comprehensive look at the intersection of medicine and addiction.